AB0592 ASSESSMENT OF KNOWLEDGE OF THE APPLICATION OF TOPICAL ANALGESICS

Background: In chronic osteoarticular pain, especially knee osteoarthritis, topical analgesics and non-steroidal anti-inflammatory drugs represent an interesting therapeutic alternative for patients with several comorbidities in order to avoid side effects medical interactions. Objectives: The aim of this work was assess how apply a analgesic. Methods: A prospective study has been conducted over period 4 weeks. Sixty-six followed osteoarthritis at different stages the disease under analgesic treatment were integrated into study. Epidemiological data, physical examination x-ray data collected. impact evaluated by Lequesne WOMAC indices. Patients asked about long they treatment, often use per week whether are massaging aching area while applying treatment. Results: studied population, majority women (87%) average age 55 years. Forty percent illiterate as 21% received college education. Patients’ occupations distributed follows: 59% housewives, retirees, 12% manual 8% non-manual occupations. most common high blood pressure (61%), diabetes (38%) osteoporosis (36%). duration development 9 radiological stage 1 (58%). site femorotibial 88% cases, patellofemoral 4% cases bi or tri-compartmental cases. affected both knees: 86% index 11. 12 1.5 stiffness 48 dysfunction. All interviewed on 5 frequency application times week. Housewives retirees used 14 working Seventy-two reported that performed massage lasting 11 minutes each application. Among secondary university education, 64% painful medication. more than 10 years tend local shorter time (an minutes). Conclusion: who taking make misuse, including less frequently recommended. level education does not seem play role knowing right way apply. However, have longer correctly. References: [1]Flores MP, Castro AP, Nascimento Jdos S. Topical analgesics. Rev Bras Anestesiol. 2012 Mar-Apr;62(2):244-52. doi: 10.1016/S0034-7094(12)70122-8. PMID: 22440379. [2]Barkin RL. pharmacology Postgrad Med. 2013 Jul;125(4 Suppl 1):7-18. 10.1080/00325481.2013.1110566911. 24547599. Disclosure Interests: None declared.